Pancreatic cancer epidemiology and demographics

Jump to navigation Jump to search

Pancreatic cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pancreatic Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pancreatic cancer epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pancreatic cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pancreatic cancer epidemiology and demographics

CDC on Pancreatic cancer epidemiology and demographics

Pancreatic cancer epidemiology and demographics in the news

Blogs on Pancreatic cancer epidemiology and demographics

Directions to Hospitals Treating Pancreatic cancer

Risk calculators and risk factors for Pancreatic cancer epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Rim Halaby, M.D. [3]

Overview

In the United States, the age-adjusted prevalence of invasive pancreatic cancer is 0.0117% in 2011.[1] The majority of pancreatic tumors are adenocarcinomas.

Epidemiology and Demographics

Prevalence

  • In the United States, the age-adjusted prevalence of invasive pancreatic cancer is 0.0117% in 2011.[1]

Incidence

  • The delay-adjusted incidence of invasive pancreatic cancer in 2011 was estimated to be 12.63 per 100,000 persons in the United States.[1]
  • In 2011, the age-adjusted incidence of invasive pancreatic cancer was 12.30 per 100,000 persons in the United States.[1]

Age

  • While the overall age-adjusted incidence of invasive pancreatic cancer in the United States between 2007 and 2011 is 10.9 per 100,000, the age-adjusted incidence of invasive pancreatic cancer by age category is:[1]
    • Under 65 years: 4 per 100,000
    • 65 and over: 69.4 per 100,000

Gender

  • In the United States, the age-adjusted prevalence of invasive pancreatic cancer by gender in 2011 is:[1]
    • In males: 0.0123%
    • In females: 0.0112%
  • In the United States, the delay-adjusted incidence of invasive pancreatic cancer by gender in 2011 is:[1]
    • In males: 14.75 per 100,000 persons
    • In females: 10.93 per 100,000 persons
  • In the United States, the age-adjusted incidence of invasive pancreatic cancer by gender on 2011 is:[1]
    • In males: 14.38 per 100,000 persons
    • In females: 10.62 per 100,000 persons

Shown below is an image depicting the delay-adjusted incidence and observed incidence of invasive pancreatic cancer by gender and race in the United States between YEAR and YEAR. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[1]

Delay-adjusted incidence and observed incidence of invasive pancreatic cancer by gender and race in the United States between 1975 and 2011

Race

  • Shown below is a table depicting the age-adjusted prevalence of invasive pancreatic cancer by race in 2011 in the United States.[1]
All Races White Black Asian/Pacific Islander Hispanic
Age-adjusted prevalence 0.0117% 0.0117% 0.0130% 0.0104% 0.0096%

Shown below is an image depicting the incidence of invasive pancreatic cancer by race in the United States between YEAR and YEAR.[1]

Incidence of invasive pancreatic cancer by race in the United States between 1975 and 2011

API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native

Percent Distribution of Invasive Pancreatic Cancer by Histology

Among patients with histologically confirmed cases of invasive pancreatic cancer, the percent distribution of the types of the disease between YEAR and YEAR in the United States are:[1]

  • Carcinoma: 97.9%
    • Epidermoid carcinoma: 0.2%
    • Adenocarcinoma: 86%
      • Adenocarcinoma not otherwise specified: 69.9%
      • Papillary adenocarcinoma: 0.1%
      • Mucinous adenocarcinoma: 2.6%
      • Mucin- producing adenocarcinoma: 1.1%
      • Inflitrating duct carcinoma: 9.8%
      • Other adenocarcinoma: 2.6%
    • Other specific carcinoma: 6.5%
      • Islet cell cracinoma: 0.9%
      • Other carcinoma: 5.7%
    • Carcinoma not otherwise specified: 5.2%
  • Sarcoma and other soft tissue tumors: 0.1%
  • Other specific types: 0.1%
  • Unspecified: 1.9%

Awareness

  • November is Pancreatic Cancer Awareness Month.
  • Purple is the traditional color chosen to represent pancreatic cancer awareness.
  • The National Cancer Institute’s cancer research budget was $4.824 billion in 2004, an estimated $52.7 million of which was devoted to pancreatic cancer.[2]
  • Research spending per pancreatic cancer patient is $1145, the lowest of any leading cancer.[3]
  • The Pancreatic Cancer Action Network (PanCAN) was created as an advocacy group for pancreatic cancer.
  • The national charity Pancreatic Cancer UK works to raise awareness in the UK

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
  2. http://pancan.org/About/pancreaticCancerStats.html
  3. http://pancan.org/About/pancreaticCancerStats.html


Template:WikiDoc Sources